CNS pipeline · person
Margaret M. FitzPatrick, M.A.
Chair of Vistagen's Board (since October 2023) and an independent director since July 2021. Founder of business advisory firm FitzPatrick & Co.; former Global Chief Communications Officer at Johnson & Johnson and SVP, Corporate Affairs at Exelon. Also lead independent director at AN2 Therapeutics.
- 1 company
Current roles
- Vistagen Therapeutics, Inc.Chair of the Board (Independent Director) · Board2021–present
Appears with
People sharing a company with Margaret.
- Ann M. Cunningham · Vistagen Therapeutics, Inc.
- Cynthia L. Anderson · Vistagen Therapeutics, Inc.
- Elissa Cote · Vistagen Therapeutics, Inc.
- Gerard Sanacora · Vistagen Therapeutics, Inc.
- Gordon Keller · Vistagen Therapeutics, Inc.
- Joanne Curley · Vistagen Therapeutics, Inc.
- Jon S. Saxe · Vistagen Therapeutics, Inc.
- Joshua S. Prince · Vistagen Therapeutics, Inc.
- Mark Wallace · Vistagen Therapeutics, Inc.
- Mary L. Rotunno · Vistagen Therapeutics, Inc.
- Maurizio Fava · Vistagen Therapeutics, Inc.
- Michael R. Liebowitz · Vistagen Therapeutics, Inc.
- Reid G. Adler · Vistagen Therapeutics, Inc.
- Sanjay Mathew · Vistagen Therapeutics, Inc.
- Shawn K. Singh · Vistagen Therapeutics, Inc.
- Thomas Laughren · Vistagen Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.